Immune System Diseases Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03016377Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALLTreatment